VSV-hIFNbeta-NIS

VSV-hIFNbeta-NIS in Treating Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia, Lymphomas, or Histiocytic/Dendritic Cell Neoplasms

Arms / Cohorts

Experimental:Group A: VSV-IFNbeta-NIS

Accepting patients

Experimental:Group D: VSV-IFNbeta-NIS + Ruxolitinib + Cemiplimab

Accepting patients

Experimental:Group E: VSV-IFNbeta-NIS + Ipilimumab + Cemiplimab

Accepting patients

Experimental:Group F: VSV-IFNbeta-NIS

Accepting patients

Experimental:Group G: VSV-IFNbeta-NIS

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.